Jun 3 |
Aurigene Pharmaceutical Services Limited, a Global CRDMO, Announces the Opening of Its Biologics Facility Offering Process Development and Clinical Scale Manufacturing Capabilities
|
May 28 |
Dr. Reddy's Laboratories Announces the Appointment of Milan Kalawadia to CEO North America
|
May 22 |
Alvotech and Dr Reddy’s partner to commercialise AVT03
|
May 21 |
Alvotech and Dr. Reddy’s Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK
|
May 21 |
Alvotech and Dr. Reddy’s collaborate for commercialization of denosumab
|